COVID-19 vaccine trials must include helminth-infected cohorts

Nat Immunol. 2022 Feb;23(2):148. doi: 10.1038/s41590-021-01116-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Africa / epidemiology
  • Animals
  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / adverse effects
  • Clinical Trials as Topic*
  • Helminthiasis / epidemiology
  • Helminthiasis / immunology*
  • Helminthiasis / parasitology
  • Helminths / immunology*
  • Helminths / pathogenicity
  • Host-Pathogen Interactions
  • Humans
  • Immunization Schedule
  • Research Design*
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity
  • Treatment Outcome
  • Vaccination
  • Vaccine Development*

Substances

  • COVID-19 Vaccines